We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.7B
AUM Growth
+$211M
Cap. Flow
-$755M
Cap. Flow %
-5.94%
Top 10 Hldgs %
33.79%
Holding
1,215
New
45
Increased
450
Reduced
295
Closed
31

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$108M
2
VER
VEREIT, Inc.
VER
+$105M
3
WELL icon
Welltower
WELL
+$102M
4
VTR icon
Ventas
VTR
+$88.9M
5
BXP icon
Boston Properties
BXP
+$86.8M

Top Sells

Rank Stock Value
1
EQR icon
Equity Residential
EQR
+$189M
2
GGP
GGP Inc.
GGP
+$166M
3
KRC icon
Kilroy Realty
KRC
+$93.2M
4
ESRT icon
Empire State Realty Trust
ESRT
+$92.1M
5
EPR icon
EPR Properties
EPR
+$59.2M

Sector Composition

Rank Sector Weight
1 Real Estate 73.5%
2 Industrials 3.95%
3 Technology 3.75%
4 Financials 2.75%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHLR
1151
Wheeler Real Estate Investment Trust
WHLR
$1.15M
– –
0
– –
CMRX
1152
DELISTED
Chimerix, Inc.
CMRX
$1K ﹤0.01%
260
– –
LUMO
1153
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1K ﹤0.01%
23
– –
BLCM
1154
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1K ﹤0.01%
18
– –
JNCE
1155
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
178
– –
CALA
1156
DELISTED
Calithera Biosciences, Inc
CALA
$1K ﹤0.01%
10
– –
TLGT
1157
DELISTED
Teligent, Inc
TLGT
$1K ﹤0.01%
30
– –
SBBP
1158
DELISTED
Strongbridge Biopharma plc.
SBBP
$1K ﹤0.01%
220
– –
NEOS
1159
DELISTED
Neos Therapeutics, Inc
NEOS
$1K ﹤0.01%
160
– –
NBRV
1160
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1K ﹤0.01%
1
– –
TTPH
1161
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1K ﹤0.01%
14
– –
RARX
1162
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1K ﹤0.01%
125
– –
FOMX
1163
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1K ﹤0.01%
207
– –
PETX
1164
DELISTED
Aratana Therapeutics, Inc.
PETX
$1K ﹤0.01%
238
– –
AKO.B icon
1165
Embotelladora Andina Series B
AKO.B
– –
-1,000
Closed -$29K
AN icon
1166
AutoNation
AN
$6.97B
– –
-2,150
Closed -$101K
ANF icon
1167
Abercrombie & Fitch
ANF
$4.17B
– –
-600
Closed -$15K
AZUL
1168
DELISTED
Azul
AZUL
– –
-500
Closed -$17K
CLDX icon
1169
Celldex Therapeutics
CLDX
$2.77B
– –
-50
Closed -$2K
CP icon
1170
Canadian Pacific Kansas City
CP
$82B
– –
-75,860
Closed -$2.68M
CRIS icon
1171
Curis
CRIS
$9.53M
– –
0
– –
EPR.PRE icon
1172
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$114M
– –
-45,070
Closed -$1.57M
KB icon
1173
KB Financial Group
KB
$41.2B
– –
-500
Closed -$29K
MCD icon
1174
PUT
McDonald's
MCD
$188B
– –
-400
Closed -$336K
MNKD icon
1175
MannKind Corp
MNKD
$1.28B
– –
-647
Closed -$1K
44 45 46
47
48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2018 Portfolio in Review

As of Q2 2018, Daiwa Securities Group held 1,215 positions worth $12.7B, up 1.7% from $12.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $755M in Q2 2018, closing 31 positions and reducing 295 holdings. Its most notable exit was Blue Buffalo Pet Products, Inc, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 73% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in VICI Properties worth $115M.

  • Daiwa Securities Group's largest Q2 2018 buy was VICI Properties: 5,575,176 shares worth $115M.
  • Daiwa Securities Group added most to VEREIT, Inc. in Q2 2018, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2018 reduction was Equity Residential, cutting an estimated $189M.
  • Daiwa Securities Group fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $5.82M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $12.7B portfolio in Q2 2018.
  • Daiwa Securities Group opened 45 new positions and closed 31 in Q2 2018.
  • Daiwa Securities Group's portfolio value rose 1.7% quarter-over-quarter to $12.7B.

Based on Daiwa Securities Group's 13F filing for Q2 2018, filed 30 Jul 2018.